| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.ortinlabsindia.com | |
| Market Cap | 16.04 Cr. | |
| Enterprise Value(EV) | 21.72 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -5.01 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 41.74 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 8.57 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 2.30 | Calculated using Price: 19.72 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 0.81 Cr. | 8,131,392 Shares |
| FaceValue | 10 | |
| About Ortin Laboratories Ltd. | ||
| Ortin Laboratories established in the year 1986 was a private limited company with a nominal capital of Rs 1 lakh to offer quality drugs and medicines to the suffering mankind. Later, in the year 1994, this private limited company converted as a public limited company with 5,060 shareholders which received good subscription from the public. These proceeds were utilised for constructing a factory in a spacious area of 25000 sq feet with all ultra-modern infrastructure as per the WHO GMP Standards to manufacture the complete range of Pharmaceutical Formulations of Tablets, Capsules, Syrups, Dry Powders & Ointments. Due to its concern for quality, the company stands as a leading and predominant pharmaceutical manufacturer of drugs and medicines of the country with turnover running in crores of rupees. | ||
| 1 Day |
|
-1.25% |
| 1 Week |
|
+1.55% |
| 1 Month |
|
+10.36% |
| 3 Month |
|
-3.43% |
| 6 Month |
|
+2.07% |
| 1 Year |
|
+0.77% |
| 2 Year |
|
-29.89% |
| 5 Year |
|
+45.93% |
| 10 Year |
|
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 4.04 | 3.65 | 2.16 | 2.86 | 5.21 | -2.31 | 5.38 | -3.57 | -0.86 | |
| Return on Capital Employed (%) | 11.55 | 11.01 | 9.58 | 10.14 | 11.76 | 8.93 | 3.27 | 1.56 | 1.66 | |
| Return on Assets (%) | 1.28 | 1.25 | 0.79 | 1 | 1.43 | -0.51 | 1.37 | -1.9 | -0.45 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 22 | 23 | 23 | 24 | 25 | 24 | 11 | 11 | 11 | 10 | |
| Non Curr. Liab. | 8 | 16 | 8 | 8 | 8 | 9 | 2 | 2 | 3 | 3 | |
| Curr. Liab. | 37 | 27 | 31 | 42 | 72 | 84 | 8 | 8 | 7 | 6 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 68 | 66 | 62 | 74 | 105 | 117 | 21 | 21 | 21 | 18 | |
| Non Curr. Assets | 24 | 35 | 23 | 21 | 23 | 24 | 15 | 15 | 15 | 15 | |
| Curr. Assets | 44 | 31 | 38 | 52 | 82 | 92 | 6 | 6 | 7 | 4 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 68 | 66 | 62 | 74 | 105 | 117 | 21 | 21 | 21 | 18 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 60 | 63 | 67 | 80 | 168 | 197 | 8 | 8 | 6 | 3 | |
| Other Income | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |
| Total Income | 61 | 64 | 67 | 80 | 168 | 198 | 8 | 8 | 6 | 3 | |
| Total Expenditure | -54 | -57 | -61 | -74 | -162 | -192 | -7 | -8 | -6 | -7 | |
| PBIDT | 7 | 6 | 6 | 6 | 7 | 6 | 1 | 1 | 1 | -3 | |
| Interest | -4 | -3 | -3 | -3 | -3 | -3 | -1 | -1 | 0 | -1 | |
| Depreciation | -2 | -2 | -2 | -2 | -2 | -2 | 0 | 0 | 0 | 0 | |
| Taxation | 0 | -1 | -1 | -1 | -1 | 1 | 0 | 0 | 0 | ||
| Exceptional Items | 0 | ||||||||||
| PAT | 1 | 1 | 1 | 1 | 1 | -1 | 1 | 0 | 0 | -4 | |
| Adjusted EPS | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | -5 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | -2 | -1 | 1 | 2 | 2 | 7 | 3 | 18 | 2 | 0 | |
| Cash Fr. Inv. | 0 | 0 | -1 | -1 | -1 | -3 | -3 | 0 | 0 | 0 | |
| Cash Fr. Finan. | 1 | 2 | 0 | -1 | 0 | -3 | -1 | -10 | 0 | 1 | |
| Net Change | -1 | 1 | 0 | 0 | 1 | 0 | -1 | 8 | 2 | 1 | |
| Cash & Cash Eqvt | 1 | 2 | 2 | -14 | -13 | -13 | -14 | -5 | -4 | -3 |
|
Tue, 16 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018 Ortin Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
|
Thu, 11 Apr 2024
Shareholders meeting Ortin Laboratories Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on April 11, 2024. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results. |
|
Sat, 06 Apr 2024
Price movement Significant movement in price has been observed in Ortin Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Ortin Laboratories Limited has submitted their response. |
| Thu, 25 Apr 2024 |
Opening at High
|
Opening at High for 2 Days
|
High Increase in 1 Month
|
Closing Near 50 SMA
|
| Wed, 24 Apr 2024 |
Higher Delivery Quantity
|
